Pregnancy outcomes for women on anti-TNF drugs for inflammatory bowel disease cared for in a tertiary maternal medicine centre: A retrospective cohort study

被引:0
|
作者
Whittall, Abigail [1 ]
Hazelhurst, Stacy [1 ]
Burden, Christy [1 ]
Neuberger, Francesca [1 ]
机构
[1] North Bristol NHS Fdn Trust, Bristol, Avon, England
关键词
D O I
暂无
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
214
引用
收藏
页码:101 / 102
页数:2
相关论文
共 50 条
  • [31] Correlation Between Histological Activity and Use of Anti-TNF in Patients With Inflammatory Bowel Disease in a Mexican Tertiary Hospital Centre
    Aleman Abitia, Dassaev
    Jesus Lopez, Gomez
    de la Fuente Korely, Trujillo
    Navarro Gerrard, Christian
    Jhonatan Aguilar, Hernandez
    Gabriel Klimek, Albarran
    Diana Bringas, Vasquez
    del Pilar Rodolfo, Ramirez
    Carlos Paredes, Amenabar
    Salamanca Garcia, Moises
    Ramos Gomez, Mayra
    Cortes Espinosa, Tomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1 - S2
  • [32] Biosimilar infliximab is effective and safe in inflammatory bowel disease patients naive to anti-TNF therapy: a tertiary centre experience
    Bortlik, M.
    Kolar, M.
    Duricova, D.
    Malickova, K.
    Hruba, V.
    Machkova, N.
    Mitrova, K.
    Lukas, M.
    Lukas, M.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S351 - S351
  • [33] Pregnancy outcomes for women with inflammatory bowel disease (IBD) under the care of a maternal medicine team
    O'Sullivan, M.
    Foster, A. B.
    Mohan, A. R.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 : 107 - 107
  • [34] Pregnancy outcomes in women with inflammatory bowel disease: a population based cohort study
    Mahadevan, U
    Sandborn, WJ
    Azmi, S
    Kane, S
    Li, DK
    Corley, D
    GASTROENTEROLOGY, 2005, 128 (04) : A322 - A323
  • [35] GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    McClinchie, Madeline
    Lakhani, Alyshah
    Abdel-Rasoul, Mahmoud
    McNicol, Megan
    Shaikhkhalil, Ala
    Boyle, Brendan
    Maltz, Ross
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S61 - S62
  • [36] GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    McClinchie, Madeline
    Lakhani, Alyshah
    Abdel-Rasoul, Mahmoud
    McNicol, Megan
    Shaikhkhalil, Ala
    Boyle, Brendan
    Maltz, Ross
    GASTROENTEROLOGY, 2023, 164 (04) : S78 - S78
  • [37] GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
    McClinchie, Madeline
    Lakhani, Alyshah
    Abdel-Rasoul, Mahmoud
    McNicol, Megan
    Shaikhkhalil, Ala
    Boyle, Brendan M.
    Maltz, Ross
    GASTROENTEROLOGY, 2023, 164 (06) : S493 - S494
  • [38] Increased Risk of Preeclampsia in Women With Inflammatory Bowel Disease on Anti-TNF Therapy
    Kattah, Andrea
    Becker, Brenda
    Kane, Sunanda
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S444 - S444
  • [39] EFFECT OF ANTI-TNF THERAPY ON RISK OF PREECLAMPSIA IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
    Patel, Nisha
    Vinsard, Daniela Guerrero
    Kattah, Andrea
    Kane, Sunanda V.
    GASTROENTEROLOGY, 2022, 162 (07) : S816 - S817
  • [40] Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
    Moens, Annick
    van der Woude, C. Janneke
    Julsgaard, Mette
    Humblet, Evelien
    Sheridan, Juliette
    Baumgart, Daniel C.
    Gilletta De Saint-Joseph, Cyrielle
    Nancey, Stephane
    Rahier, Jean-Francois
    Bossuyt, Peter
    Cremer, Anneline
    Dewit, Sophie
    Eriksson, Carl
    Hoentjen, Frank
    Krause, Thomas
    Louis, Edouard
    Macken, Elisabeth
    Milenkovic, Zoran
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Bar-Gil Shitrit, Ariella
    Ferrante, Marc
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 129 - 138